School of Medicine, Universidade Federal de Alagoas (UFAL), Maceió, AL, Brazil.
Braz J Infect Dis. 2013 May-Jun;17(3):319-23. doi: 10.1016/j.bjid.2012.10.021. Epub 2013 May 15.
To test the validity of the polymerase chain reaction for diagnosing American visceral leishmaniasis, 88 suspected cases were studied. Diagnosis was confirmed in 47 (53.5%) and ruled out in 41 (46.5%) patients. Samples of bone marrow and peripheral blood were processed by polymerase chain reaction to evaluate the sensitivity and specificity of the test and its agreement beyond chance with microscopy examination. The polymerase chain reaction was positive in bone marrow of 100% of the patients with amastigotes seen with microscopy examination, and in 59.5% in those where no parasite were seen. Agreement beyond chance between visualization of the parasite in bone marrow aspirates and polymerase chain reaction was considered weak (Kappa=0.41). Concordance between polymerase chain reaction of bone marrow aspirates and of peripheral blood was considered excellent (Kappa=0.88). The test turned out positive in all bone marrow aspirates of those with the disease and whereas the positivity rate was 58.5% among those without the disease, with specificity rate of 41.5%.
为了测试聚合酶链反应诊断内脏利什曼病的有效性,对 88 例疑似病例进行了研究。47 例(53.5%)确诊,41 例(46.5%)排除。通过聚合酶链反应处理骨髓和外周血样本,以评估该检测的灵敏度、特异性及其与显微镜检查的一致性。在显微镜检查可见无鞭毛体的患者中,骨髓聚合酶链反应阳性率为 100%,在未观察到寄生虫的患者中为 59.5%。骨髓抽吸物中寄生虫可视化与聚合酶链反应之间的一致性被认为是弱的(Kappa=0.41)。骨髓抽吸物与外周血聚合酶链反应之间的一致性被认为是极好的(Kappa=0.88)。该检测在所有患有该病的骨髓抽吸物中均呈阳性,而在未患该病的患者中阳性率为 58.5%,特异性率为 41.5%。